Preventing nosocomial bloodstream infection in very low birth weight infants

Seminars in Neonatology

Volumn 7, Issue 4, 2002, Pages 325-333

  Edwards, William H ^a  

^a CHILDREN S HOSPITAL AT DARTMOUTH   (United States)

Author keywords

Cross infection; Infant, premature, diseases, infant, premature; Infant, very low birth weight; Intensive care, neonatal; Quality assurance, health care; Sepsis; Total quality management

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN;

ANTIBIOTIC THERAPY; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BREAST MILK; DIAGNOSTIC ACCURACY; DISEASE TRANSMISSION; DISINFECTION; ENTERIC FEEDING; HAND WASHING; HOSPITAL INFECTION; HUMAN; INFANT; INFECTION PREVENTION; INTRAVASCULAR CATHETER; NEWBORN SEPSIS; PARENTERAL NUTRITION; REVIEW; SKIN CARE; VERY LOW BIRTH WEIGHT;

EID: 0036669461     PISSN: 10842756     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1084-2756(02)99125-6     Document Type: Review

References (82)

1. Lemons JA, Bauer CR, Oh W, et al. Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics 2001; 107(1): E1.
2. Gray JE, Richardson DK, McCormick MC, et al. Coagulase-negative staphylococcal bacteremia among very low birth weight infants: Relation to admission illness severity, resource use, and outcome. Pediatrics 1995; 95(2): 225-230.
3. Stoll BJ, Gordon T, Korones SB, et al. Late-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network. The Journal of Pediatrics 1996; 129(1): 63-71.
4. Makhoul IR, Sujov P, Smolkin T, et al. Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: A national survey. Pediatrics 2002; 109(1): 34-39.
5. Gaynes RP, Edwards JR, Jarvis WR, et al. Nosocomial infections among neonates in high-risk nurseries in the United States. National Nosocomial Infections Surveillance System. Pediatrics 1996; 98(3 Pt 1): 357-361.
6. Fanaroff AA, Korones SB, Wright LL, et al. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network. The Pediatric Infectious Disease Journal 1998; 17(7): 593-598.
7. Brodie SB, Sands KE, Gray JE, et al. Occurrence of nosocomial bloodstream infections in six neonatal intensive care units. The Pediatric Infectious Disease Journal 2000; 19(1): 56-65.
8. Freeman J, Platt R, Epstein MF, et al. Birth weight and length of stay as determinants of nosocomial coagulase-negative staphylococcal bacteremia in neonatal intensive care unit populations: Potential for confounding. American Journal of Epidemiology 1990; 132(6): 1130-1140.
9. Avila-Figueroa C, Goldmann DA, Richardson DK, et al. Intravenous lipid emulsions are the major determinant of coagulase-negative staphylococcal bacteremia in very low birth weight newborns. The Pediatric Infectious Disease Journal 1998; 17(1): 10-17.
10. Stoll BJ, Temprosa M, Tyson JE, et al. Dexamethasone therapy increases infection in very low birth weight infants. Pediatrics 1999; 104(5): e63.
11. Gaynes RP, Horan TC. Surveillance of Nosocomial Infections. In: Mayhall CG (ed.) Hospital Epidemiology and Infections Control. Baltimore, MD: Williams & Wilkins, 1996;1017-1031.
12. Horbar JD, Rogowski J, Plsek PE, et al. Collaborative quality improvement for neonatal intensive care. Pediatrics 2001; 107: 14-22.
13. Horbar JD (ed.). Vermont Oxford Network 2000 Database Summary. Burlington, VT: Vermont Oxford Network, 2001.
14. Eggimann P, Harbarth S, Constantin MN, et al. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000; 355(9218): 1864-1868.
15. Maas A, Flament P, Pardou A, et al. Central venous catheter-related bacteraemia in critically ill neonates: Risk factors and impact of a prevention programme. The Journal of Hospital Infection 1998; 40(3): 211-224.
16. Clinical sepsis and death in a newborn nursery associated with contaminated parenteral medications - Brazil, 1996. MMWR. Morbidity and Mortality Weekly Report 1998; 47(29): 610-612.
17. Sohn AH, Garrett DO, Sinkowitz-Cochran RL, et al. Prevalence of nosocomial infections in neonatal intensive care unit patients: Results from the first national point-prevalence survey. The Journal of Pediatrics 2001; 139(6): 821-827.
18. McNeeley DF, Saint-Louis F, Noel GJ. Neonatal enterococcal bacteremia: an increasingly frequent event with potentially untreatable pathogens. The Pediatric Infectious Disease Journal 1996; 15(9): 800-805.
19. Lee HK, Lee WG, Cho SR. Clinical and molecular biological analysis of a nosocomial outbreak of vancomycin-resistant enterococci in a neonatal intensive care unit. Acta Paediatrica 1999; 88(6): 651-654.
20. Recommendations for preventing the spread of vancomycin resistance. Hospital Infection Control Practices Advisory Committee (HICPAC). Infection Control and Hospital Epidemiology 1995; 16(2): 105-113.
21. Foca M, Jakob K, Whittier S, et al. Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit. The New England Journal of Medicine 2000; 343(10): 695-700.
22. Grundmann H, Kropec A, Hartung D, et al. Pseudomonas aeruginosa in a neonatal intensive care unit: Reservoirs and ecology of the nosocomial pathogen. The Journal of Infectious Diseases 1993; 168(4): 943-947.
23. Makhoul IR, Kassis I, Smolkin T, et al. Review of 49 neonates with acquired fungal sepsis: further characterization. Pediatrics 2001; 107(1): 61-66.
24. Benjamin DK Jr, Ross K, McKinney RE Jr, et al. When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. Pediatrics 2000; 106(4): 712-718.
25. Kaufman D, Boyle R, Hazen KC, et al. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. The New England Journal of Medicine 2001; 345(23): 1660-1666.
26. Dietzman DE, Fischer GW, Schoenknecht FD. Neonatal Escherichia coli septicemia - Bacterial counts in blood. The Journal of Pediatrics 1974; 85(1): 128-130.
27. Ilstrup DM, Washington II JA. The importance of volume of blood cultured in the detection of bacteremia and fungemia. Diagnostic Microbiology and Infectious Disease 1983; 1(2): 107-110.
28. Schelonka RL, Chai MK, Yoder BA, et al. Volume of blood required to detect common neonatal pathogens. The Journal of Pediatrics 1996; 129(2): 275-278.
29. Schifman RB, Strand CL, Meier FA, et al. Blood culture contamination: A College of American Pathologists Q-Probes study involving 640 institutions and 497134 specimens from adult patients. Archives of Pathology and Laboratory Medicine 1998; 122(3): 216-221.
30. Van Houten MA, Uiterwaal CS, Heesen GJ, et al. Does the empiric use of vancomycin in pediatrics increase the risk for Gram-negative bacteremia? The Pediatric Infectious Disease Journal 2001; 20(2): 171-177.
31. de Man P, Verhoeven BA, Verbrugh HA, et al. An antibiotic policy to prevent emergence of resistant bacilli. Lancet 2000; 355(9208): 973-978.
32. Karlowicz MG, Buescher ES, Surka AE. Fulminant lateonset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy. Pediatrics 2000; 106(6): 1387-1390.
33. Garcia-Prats JA, Cooper TR, Schneider VF, et al. Rapid detection of microorganisms in blood cultures of newborn infants utilizing an automated blood culture system. Pediatrics 2000; 105(3 Pt 1): 523-527.
34. Newport MT, John JF, Michel YM, et al. Endemic Serratia marcescens infection in a neonatal intensive care nursery associated with gastrointestinal colonization. Pediatric Infectious Disease 1985; 4(2): 160-167.
35. Huebner J, Pier GB, Maslow JN, et al. Endemic nosocomial transmission of Staphylococcus epidermidis bacteremia isolates in a neonatal intensive care unit over 10 years. The Journal of Infectious Diseases 1994; 169(3): 526-531.
36. Huebner J, Goldmann DA. Coagulase-negative staphylococci: Role as pathogens. Annual Review of Medicine 1999; 50: 223-236.
37. Aiello AE, Larson EL. What is the evidence for a causal link between hygiene and infections? The Lancet Infectious Diseases 2002; 2(2): 103-110.
38. Garner JS, Favero MS. CDC guidelines for the prevention and control of nosocomial infections. Guideline for handwashing and hospital environmental control, 1985. Supersedes guideline for hospital environmental control published in 1981. American Journal of Infection Control 1986; 14(3): 110-129.
39. Larson EL. APIC guideline for handwashing and hand antisepsis in health care settings. American Journal of Infection Control 1995; 23(4): 251-269.
40. Ward V, Wilson J, Taylor L, et al. Preventing Hospital-Acquired Infections: Clinical Guidelines. London: Public Health Laboratory Service, 1997.
41. Pratt RJ, Pellowe C, Loveday HP, et al. The epic project: developing national evidence-based guidelines for preventing healthcare associated infections. Phase I: Guidelines for preventing hospital-acquired infections. Department of Health (England). The Journal of Hospital Infection 2001; 47(Suppl): S3-82.
42. Shojania KG, Duncan BW, McDonald KM, et al (eds). Making Health Care Safer: A Critical Analysis of Patient Safety Practices. Evidence Report/Technology Assessment No. 43 (Prepared by the University of California at San Francisco - Stanford Evidence-based Practice Center under Contract No, 290-97-0013), AHRQ Publication No. 07-E058. Rockville, MD: Agency for Healthcare Research in Quality, 2001.
43. Harris AD, Samore MH, Nafziger R, et al. A survey on handwashing practices and opinions of healthcare workers. The Journal of Hospital Infection 2000; 45(4): 318-321.
44. Kaplan LM, McGuckin M. Increasing handwashing compliance with more accessible sinks. Infection Control 1986; 7(8): 408-410.
45. Larson EL, Bryan JL, Adler LM, et al. A multifaceted approach to changing handwashing behavior. American Journal of Infection Control 1997; 25(1): 3-10.
46. Larson E, Silberger M, Jakob K, et al. Assessment of alternative hand hygiene regimens to improve skin health among neonatal intensive care unit nurses. Heart and Lung: The Journal of Critical Care 2000; 29(2): 136-142.
47. Muto CA, Sistrom MG, Farr BM. Hand hygiene rates unaffected by installation of dispensers of a rapidly acting hand antiseptic. American Journal of Infection Control 2000; 28(3): 273-276.
48. Bischoff WE, Reynolds TM, Sessler CN, et al. Handwashing compliance by health care workers: The impact of introducing an accessible, alcohol-based hand antiseptic. Archives of Internal Medicine 2000; 160(7): 1017-1021.
49. Maury E, Alzieu M, Baudel JL, et al. Availability of an alcohol solution can improve hand disinfection compliance in an intensive care unit. American Journal of Respiratory and Critical Care Medicine 2000; 162(1): 324-327.
50. Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet 2000; 356(9238): 1307-1312.
51. Voss A, Widmer AF. No time for handwashing!? Handwashing versus alcoholic rub: can we afford 100% compliance? Infection Control and Hospital Epidemiology 1997; 18(3): 205-208.
52. Tibballs J. Teaching hospital medical staff to handwash. The Medical Journal of Australia 1996; 164(7): 395-398.
53. McGuckin M, Waterman R, Porten L, et al. Patient education model for increasing handwashing compliance. American Journal of Infection Control 1999; 27(4): 309-314.
54. McGuckin M, Waterman R, Storr IJ, et al. Evaluation of a patient-empowering hand hygiene programme in the UK. The Journal of Hospital Infection 2001; 48(3): 222-227.
55. Larson EL, Hughes CA, Pyrek JD, et al. Changes in bacterial flora associated with skin damage on hands of health care personnel. American Journal of Infection Control 1998; 26(5): 513-521.
56. Pottinger J, Burns S, Manske C. Bacterial carriage by artificial versus natural nails. Abstracts-On-Line: The Society for Healthcare Epidemiology of America 1959; 17(6): 340-344.
57. Moolenaar RL, Crutcher JM, San Joaquin VH, et al. A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: Did staff fingernails play a role in disease transmission? Infection Control and Hospital Epidemiology 2000; 21(2): 80-85.
58. Davey AM, Wagner CL, Cox C, et al. Feeding premature infants while low umbilical artery catheters are in place: A prospective, randomized trial. The Journal of Pediatrics 1994; 124(5 Pt I): 795-799.
59. Tyson JE, Kennedy KA. Minimal enteral nutrition for promoting feeding tolerance and preventing morbidity in parenterally fed infants. Cochrane Database of Systematic Reviews 2000(2); CD000504.
60. el-Mohandes AE, Picard MB, Simmens SJ, et al. Use of human milk in the intensive care nursery decreases the incidence of nosocomial sepsis. Journal of Perinatology 1997; 17(2): 130-134.
61. Schanler RJ, Shulman RJ, Lau C. Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk versus preterm formula. Pediatrics 1999; 103(6 Pt 1): 1150-1157.
62. Hylander MA, Strobino DM, Dhanireddy R. Human milk feedings and infection among very low birth weight infants. Pediatrics 1998; 102(3): E38.
63. Poindexter BB, Ehrenkranz RA, Stoll BJ, et al. Parenteral glutamine supplementation in ELBW infants: A multicenter randomized clinical trial. Pediatric Research 2002; 51(4, Part 2): 317A.
64. Tubman TR, Thompson SW. Glutamine supplementation for prevention of morbidity in preterm infants. Cochrane Database of Systematic Reviews 2001(4); CD001457.
65. Benjamin DK Jr, Miller W, Garges H, et al. Bacteremia, central catheters, and neonates: when to pull the line. Pediatrics 2001; 107(6): 1272-1276.
66. Fleer A, Verhoef J, Pascual Hernandez A. Coagulase-negative staphylococci as nosocomial pathogens in neonates. The role of host defense, artificial devices, and bacterial hydrophobicity. American Journal of Medicine 1986; 80(6B): 161-165.
67. Mermel LA. Prevention of intravascular catheter-related infections. Annals of Internal Medicine 2000; 132(5): 391-402.
68. Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infection Control and Hospital Epidemiology 1994; 15(4 Pt 1): 231-238.
69. Sherertz RJ, Ely EW, Westbrook DM, et al. Education of physicians-in-training can decrease the risk for vascular catheter infection. Annals of Internal Medicine 2000; 132(8): 641-648.
70. Linares J, Sitges-Serra A, Garau J, et al. Pathogenesis of catheter sepsis: A prospective study with quantitative and semiquantitative cultures of catheter hub and segments. Journal of Clinical Microbiology 1985; 21(3): 357-360.
71. Salzman MB, Isenberg HD, Shapiro JF, et al. A prospective study of the catheter hub as the portal of entry for microorganisms causing catheter-related sepsis in neonates. The Journal of Infectious Diseases 1993; 167(2): 487-490.
72. Mueller-Premru M, Gubina M, Kaufmann ME, et al. Use of semi-quantitative and quantitative culture methods and typing for studying the epidemiology of central venous catheter-related infections in neonates on parenteral nutrition. Journal of Medical Microbiology 1999; 48(5): 451-460.
73. McCarthy MC, Shives JK, Robison RJ, et al. Prospective evaluation of single and triple lumen catheters in total parenteral nutrition. JPEN, Journal of Parenteral and Enteral Nutrition 1987; 11(3): 259-262.
74. Sitges-Serra A, Hernandez R, Maestro S, et al. Prevention of catheter sepsis: The hub. Nutrition 1997; 13(4 Suppl): 30S-35S.
75. Salzman MB, Isenberg HD, Rubin LG. Use of disinfectants to reduce microbial contamination of hubs of vascular catheters. Journal of Medical Microbiology 1993; 31(3): 475-479.
76. Segura M, Alvarez-Lerma F, Tellado JM, et al. A clinical trial on the prevention of catheter-related sepsis using a new hub model. Annals of Surgery 1996; 223(4): 363-369.
77. Mermel LA. New technologies to prevent intravascular catheter-related bloodstream infections. Emerging Infectious Diseases 2001; 7(2): 197-199.
78. Craft AP, Finer NN, Barrington KJ. Vancomycin for prophylaxis against sepsis in preterm neonates [Systematic Review]. Cochrane Database of Systematic Reviews 2002; 1.
79. Nopper AJ, Horii KA, Sookdeo-Drost S, et al. Topical ointment therapy benefits premature infants. The Journal of Pediatrics 1996; 128(5 Pt 1): 660-669.
80. Edwards WH, Conner JM, Soll RF, et al. The Effect of Aquaphor® Original Emollient Ointment on Nosocomial Sepsis Rates nd Skin Integrity in Infants of Birth Weight 501 to 1000 Grams. Pediatric Research 2001; 49(4 part 2): 388A.
81. Campbell JR, Zaccaria E, Baker CJ. Systemic candidiasis in extremely low birth weight infants receiving topical petrolatum ointment for skin care: A case-control study. Pediatrics 2000; 105(5): 1041-1045.
82. Ramsey K, Malone S, Fey P, et al. Aquaphor as a source of colonization and subsequent bloodstream infections among very low birthweight neonates. Abstracts-On-Line: The Society for Healthcare Epidemiology of America 1998.